NEW
Berinert

Berinert

Manufacturer:

CSL Behring

Distributor:

Primal
Concise Prescribing Info
Contents
Human C1-esterase inhibitor
Indications/Uses
Acute episodes of hereditary angioedema type I & II (HAE).
Dosage/Direction for Use
Adult & paed patient 20 IU/kg by slow IV inj or infusion (4 mL/min).
Contraindications
Special Precautions
Immediately stop administration in case of allergic or anaphylactic-type reactions. Patients w/ laryngeal oedema; patients on a controlled Na diet. Potential risks associated w/ home-treatment & self-administration. Possibility of transmitting infective agents. Appropriate vaccination (hepatitis A & B) should be generally considered for patients in regular/repeated receipt of human plasma-derived products. Pregnancy & lactation.
Adverse Reactions
Rare: Development of thrombosis; rise in temp, inj site reactions; allergic or anaphylactic-type reactions.
MIMS Class
Vaccines, Antisera & Immunologicals / Immunosuppressants
ATC Classification
B06AC01 - c1-inhibitor, plasma derived ; Belong to the class of drugs used in the treatment of hereditary angioedema.
Presentation/Packing
Form
Berinert powd & solvent for soln for inj/infusion 500 IU
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in